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Training family to assist with physiotherapy for older people transitioning from 
hospital to the community: a pilot randomised controlled trial. 
 
Abstract 
Objective: To investigate the safety and effectiveness of augmenting physiotherapy with 
family-assisted therapy, to inform a future, fully-powered trial. 
Design: Parallel pilot randomised controlled trial. 
Setting: Transition Care Program. 
Participants: Thirty-five older adults with multimorbidity, recently hospitalised, with a mean 
age of 84.1 years (standard deviation 6.1 years) and mean Modified Barthel Index of 67.8 
units (standard deviation 19.2 units), and 40 family members. 
Interventions: The control group (n=18) received usual physiotherapy care. The 
experimental group (n=17) received usual physiotherapy care and family-assisted therapy 
from a family member trained by a physiotherapist. 
Main measures: Primary outcomes were falls-related self-efficacy measured by the Short 
Falls Efficacy Scale International and falls during the intervention period. Secondary 
outcomes included daily steps, quality of life (EQ-5D-3L and ICECAP-O), Modified Barthel 
Index and Modified Caregiver Strain Index. 
Results: There were no between-group differences for falls-related self-efficacy. Relative to 
the control group, the experimental group was observed to have a reduced risk of falling 
(relative risk 0.38, 95% CI 0.09 to 1.60) and a reduced falls rate (incidence rate ratio 0.22, 
95% CI 0.04 to 1.20) was of borderline statistical significance. The experimental group 
walked a mean of 944 daily steps more than the control group (95% CI 139 to 1748) and had 
a significant reduction in activity limitation. There were no between-group differences for 
quality of life or caregiver strain. 
Conclusion: Augmenting physiotherapy with family-assisted therapy is feasible for older 
people transitioning from hospital to the community. A fully-powered randomised controlled 
trial is indicated. 
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Introduction 
The hazards of hospitalisation, including bed rest and injurious falls, can make transitioning 
home difficult for older adults with multimorbidity.1-3 Programs such as Transition Care in 
Australia4 and Intermediate Care in the United Kingdom5 aim to support older people with 
time and therapy to facilitate their return to community living. Physiotherapy can facilitate 
recovery of physical function6 but the amount of therapy received by patients in transitional 
programs is often low.7 
Family-assisted therapy may augment physiotherapy for older people in transitional 
programs. A systematic review found allied health therapy provided by families can improve 
outcomes, but most trials investigated parent-led speech pathology interventions for 
children.8 A Cochrane review of six studies (333 participants) found very low to moderate-
quality evidence that caregiver-mediated exercise may improve outcomes for people after 
stroke (mean age 60 years).9 The largest randomised controlled trial in this field included 
1,250 participants with stroke.10 No differences in patient outcomes were found. However, 
rather than augmenting services, that trial studied task shifting11 of stroke rehabilitation to 
family, as most patients had no access to post-discharge services. No randomised controlled 
trials have investigated family-assisted therapy to augment physiotherapy for older adults 
with multimorbidity, nor have there been trials focused on outcomes specifically relevant to 
this group such as the prevention of falls. 
There is concern that involving family in delivering therapy for older people may be unsafe 
and burdensome. A qualitative study involving patients, family members, a hospital 
consumer group and physiotherapists associated with a transitional care program reported 
positive aspects to family involvement.12 Yet patients and physiotherapists were concerned 
about increasing caregiver burden, and physiotherapists and consumers were mindful of 
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safety. Trials investigating this approach for people after stroke found no increase in adverse 
events including falls, and no increase in caregiver burden.9, 10 However, these risks are 
important for older people with multimorbidity3, 13 and need consideration. 
Therefore, the aim of this pilot randomised controlled trial was to investigate family-assisted 
therapy to augment physiotherapy for older people transitioning from hospital to the 
community, to inform a future, fully-powered trial. Our primary objective was to explore the 
effects of the intervention on falls and falls-related self-efficacy. The secondary objective was 
to determine the effect on clinical outcomes and impact on family members. 
 
Methods 
A pilot randomised controlled trial was conducted with two parallel groups and 1:1 
allocation. Participants were recruited from December 2016 until June 2018. Follow up was 
completed by September 2018. An experimental group receiving family-assisted therapy in 
addition to usual physiotherapy care was compared with a control group receiving usual 
physiotherapy care only. The trial was prospectively registered with the Australian New 
Zealand Clinical Trials Registry (ID number ACTRN12616000565448) and approved by the 
Austin Health Human Research Ethics Committee (HREC/16/AUSTIN/502) and the 
university ethics committee. All participants provided written, informed consent.  
Participants were patients and family members of patients admitted to the Transition Care 
Program at a metropolitan health service in Melbourne, Australia. To differentiate between 
these two groups of participants, we will refer to them as ‘patients’ and ‘family members’ 
respectively in this paper. The Transition Care Program included 72 residential beds in 
hospitals and nursing homes. Patients in this publicly funded program have access to nursing 
and personal care, case management and allied health services in a residential bed or at home, 
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for up to 12 weeks. Patients in Transition Care who may have been eligible were provided 
with written information by clinicians and flagged to the research team who then assessed for 
eligibility and offered the opportunity to consent. 
To be eligible for inclusion in the trial, patients had to be admitted to residential Transition 
Care at the time of recruitment. They had to be able to follow single-stage commands and to 
stand with the assistance of no more than one person, to enable family members to safely 
help with functional exercises. Basic English comprehension, as evaluated by the ability to 
participate in basic conversation about the trial, was required. Patients were not excluded due 
to impaired cognition. The presence of cognitive impairment was documented if recorded in 
the medical record. Patients were also required to have a willing, eligible family member or 
friend available to assist with the intervention.  
Eligible family members were aged 18 years or older, available to assist with therapy at least 
three times weekly, physically fit as assessed by self-report, and able to comprehend English 
language. Patients were permitted to invite more than one family member to participate.  
Randomly permuted blocks of four and six were generated by a researcher not involved in 
recruitment, the intervention or data collection, using an online program 
(http://www.randomization.com). The same researcher then prepared sequentially numbered, 
opaque envelopes for group allocation. Participants were enrolled by another researcher and 
assigned to interventions by opening the next envelope in the sequence. 
Patients allocated to the control group received usual-care physiotherapy from clinicians in 
Transition Care. Usual-care interventions included mobility training, exercise, caregiver 
training, and discharge planning provided by a physiotherapist or allied health assistant at an 
average frequency of two sessions per week (sessions could be of variable duration).7  
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The experimental group participated in family-assisted therapy, in addition to usual care. 
Family-assisted therapy was tailored to patient goals and family members were encouraged to 
conduct at least three therapy sessions per week of a length that fitted the participants’ 
preference. Family-assisted therapy included transfer practice, walking, or simple exercises 
considered safe for the family member to assist with.12  
Family members were offered 60-minute face-to-face appointments at least weekly over four 
weeks, with a member of the research team who was a physiotherapist with 15 years of 
experience in rehabilitation for older people, to learn how to provide the intervention and for 
the physiotherapist to monitor progress. Exercises were documented on an exercise sheet and 
falls/exercise diary (Appendix 1). Appointments were generally during business hours 
Monday to Friday, unless otherwise requested by family members. Participants also received 
contact via telephone, email or text message to provide support, monitor progress and answer 
questions.  
Outcomes (self-reported questionnaires and physical activity monitoring) were measured at 
the beginning and end of the intervention (Week 0 and Week 5). Baseline measures were 
completed prior to randomisation. Follow-up self-reported questionnaires were completed by 
the participants without assistance unless required. Physical activity and questionnaire data 
were entered by a researcher blind to group allocation.  
The primary outcomes were falls-related self-efficacy (self-report measure) and the number 
of falls from baseline to the end of the intervention period (direct measure) expressed as a 
risk ratio and incidence rate ratio. Falls-related self-efficacy was measured by the Short Falls 
Efficacy Scale – International, a valid and reliable patient-reported scale on concern about 
falling when participating in daily activities.14 A score of zero indicates no concern and the 
maximum of 28 indicates severe concern.14 Participants were asked to record falls on a falls 
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diary and were reminded to complete the diary via email or verbal reminders. Cross-checking 
of falls information against the hospital incident reporting system and patient medical files 
was completed to reduce the likelihood of missing data.15 
Secondary outcomes were:  
• Physical activity measured by an accelerometer (activPAL, PAL technologies, 
Glasgow), which each patient wore for three to nine days for 24 hours per day. The 
accelerometer measured daily steps and time spent walking, standing, and sitting or 
lying and has been validated for use with older people.16 If less than three days of data 
were available, these data were considered missing and were not included in analyses. 
• Health-related quality of life measured using the EQ-5D-3L (three-level version of the 
EuroQoL five-dimensional health-related quality of life questionnaire). The visual 
analogue scale component is measured from 0 to 100 with 100 indicating higher 
health-related quality of life. The index ranges from 0 to 1, with 1 indicating higher 
health-related quality of life. This measure has been used in Transition Care.17 
• Capability-related quality of life measured using the ICECAP-O tariff, with scores 
ranging from 0 to 1, with 1 indicating higher capability-related quality of life.17 
• Impact on family members measured with the Modified Caregiver Strain Index, a 13-
item instrument which adds a “yes – sometimes” response option to the original 
dichotomous options. Scores range from 0 to 26, with a higher score indicating higher 
caregiver strain.18, 19 
• Activity limitation on a 0 to 100 scale measured with the Modified Barthel Index,20 
with higher scores indicative of independence on activity, on admission to and 
discharge from Transition Care. 
• Discharge destination recorded as home environment, residential care or other. 
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• Length of stay, the number of nights a participant was admitted to Transition Care. 
• Adherence to exercise and the number of minutes of therapy provided by family 
members, recorded in the exercise diary (Appendix 1).  
To gain a preliminary understanding of the effect of the intervention on clinical outcomes, a 
sample size sufficient to detect a large, clinically significant between-group difference in 
falls-related self-efficacy of almost 6 units in older adults,14 assuming an effect size of 1.0, at 
a power of 0.8 and an alpha level of 0.05, was sought. It was calculated that a sample size of 
34 (17 patients in each group) would be adequate. The minimal clinically important 
difference for the Short Falls Efficacy Scale – International has not been reported but was 
estimated to be 3 units, based on half a standard deviation of mean scores21 reported by adults 
over 80.14 
Means were compared between the experimental and control groups at Week 5 with analysis 
of covariance (ANCOVA) using baseline values as covariates (IBM SPSS version 24 
statistical software).22 Standardised mean differences were calculated from change scores 
from Week 0 to Week 5, divided by the standard deviation of the difference scores. 
Standardised mean differences, otherwise known as effect sizes, were regarded as small at 
0.2, moderate at 0.5 and large at 0.8.23 The relative risk ratio was calculated for patients who 
had one or more falls between Week 0 and Week 5. The incidence rate ratio, based on 
negative binomial regression, was calculated for falls events between Week 0 and Week 5 
(StataCorp STATA version 12 statistical software). EQ-5D-3L indices were calculated using 
Australian weights24 and ICECAP-O using a general population algorithm developed in Great 
Britain.25 Consistent with the principle of intention to treat, all available data were analysed 
according to group allocation, without regard to level of adherence. The trial was conducted 
in accordance with the registered trial protocol. 
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Results 
Thirty-five patients and 40 family members consented to participate; 17 patients and 20 of 
their family members were allocated to receive family-assisted therapy in addition to usual-
care physiotherapy, and 18 patients and 20 of their family members were allocated to receive 
usual-care physiotherapy only (Figure 1). One patient was recruited in addition to the planned 
sample size as two were offered the final place in the trial and both consented. All patients 
received their intervention as allocated. Week 1 of the trial was an average of 23 days (SD 
17.4) after admission to Transition Care and Week 5 an average 11 days (SD 31.9) before 
discharge.  
[Insert Figure 1 about here] 
The two groups were similar regarding age, gender, diagnosis, comorbidities and assistance 
required to stand or walk. Family members in the experimental group were younger than in 
the control group, with more retirees in the control group (n=8) (Table 1).  
[Insert Table 1 about here] 
Compliance with trial method 
Patients in the experimental group received an average of three family-assisted therapy 
sessions per week (Table 2). Therapy goals expressed by patients included improving 
functional mobility (n=10), increasing leg strength (n=2), community participation (n=3) and 
building confidence (n=2). Families received training about exercise prescription, mobility 
retraining, monitoring of pain and fatigue, benefits of physical activity, and walking 
programs. One family member in the experimental group did not conduct any exercise 
sessions due to conflicting family responsibilities. Other reported reasons for missed sessions 
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planned by family members included patient illness or appointments, family member 
commitments, and the weather. Treating physiotherapists reported some patients in the 
control group received walking assistance from their families, but specific data on what 
patients in the control group received were not collected.  
[Insert Table 2 about here] 
No serious adverse events were reported, and no falls occurred during family-assisted therapy 
sessions. One patient sustained a 1 mm skin tear on removal of an accelerometer in Week 0 
that resolved without further action. This patient did not have an accelerometer fitted at Week 
5. Three patients did not have accelerometers fitted due to concerns about their skin integrity. 
Accelerometers were worn for a median of 5 days in Weeks 0 and 5. One accelerometer 
malfunctioned in Week 0 and only recorded two days of data and another patient in Week 5 
removed the monitor after two days. There were a small number of missing data for patient-
reported outcome measures. The number of participants included in each analysis is detailed 
in Table 3. 
[Insert Table 3 about here] 
Effect of intervention 
There were no significant between-group differences for the primary outcome measures. Two 
of 16 patients (13%) in the experimental group fell one or more times during the intervention 
period compared to 6 of 18 patients (33%) in the control group, resulting in a relative risk of 
0.38 (95% CI 0.09 to 1.60, p=0.19). The experimental group had an observed falls rate of 
78% less than the control group (incidence rate ratio 0.22, 95% CI 0.04 to 1.20, p=0.08) that 
approached but did not reach statistical significance. The between-group difference for Short 
Falls Efficacy Scale – International scores was -0.7 units (95% CI -3.0 to 1.7) with a small 
effect size of 0.2 observed in favour of the experimental group (Table 3). 
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Patients in the experimental group doubled their daily steps, walking an average of 944 daily 
steps more than those in the control group (95% CI 139 to 1748). There were no significant 
between-group differences for other measures of physical activity although small to large 
effect sizes favouring the experimental group were observed (Table 3). There was no 
significant between-group difference for health-related quality of life or capability-related 
quality of life (Table 3). There was also no between-group difference for the Modified 
Caregiver Strain Index, with an observed change of -1.2 (95% CI -3.6 to 1.2) and a moderate 
effect size of 0.6 observed in favour of the experimental group.  
Change in activity limitation (the Modified Barthel Index) favoured the experimental group 
with a mean between-group difference of 21.5 points (95% CI 0.8 to 42.2, p=0.04). There 
was no between-group difference for discharge destination (relative risk ratio of nursing 
home admission for experimental group 0.53, 95% CI 0.26 to 1.09, p=0.08) or length of stay 
(mean difference -6.0 days, 95% CI -29.5 to 17.6, p=0.61). 
 
Discussion 
Our findings suggest family-assisted therapy to augment physiotherapy for older people 
transitioning from hospital to the community may be safe and improve clinical outcomes. A 
phase III randomised controlled trial is indicated. The experimental group were observed to 
have a lower falls rate than the group receiving usual care only. The incidence rate ratio was 
of borderline statistical significance (p=0.08) in favour of the experimental group, an 
inconclusive result which suggests the intervention may be effective with the effect size 
maintained in a larger trial.26 Patients in the experimental group also walked almost twice the 
daily steps than those who did not receive the intervention, and had a significant reduction in 
activity limitation. It is likely these results were achieved alongside a moderate reduction in 
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caregiver strain.26 No between-group difference was found for health-related or capability-
related quality of life. If the effects found of this trial were maintained in a larger, fully-
powered study, it would result in significant benefits for older people transitioning from 
hospital to the community.  
The weaknesses of this pilot study could be overcome in a future, definitive trial. Lack of 
follow-up was a major limitation as positive results may not have been maintained beyond 
the end of the four-week intervention period. However, this study demonstrated in a group of 
older adults with multi-morbidity, a four-week trial is feasible, given the low drop-out rate 
and a recruitment rate of 43%, only slightly lower that the mean recruitment rate of 51% 
described in a systematic review of recruitment rates of trials involving patient and caregiver 
dyads.27 The sample had low representation of culturally and linguistically diverse groups 
which may limit generalisability if maintained in a larger trial. A cost-effectiveness analysis 
was not conducted and would be important to include alongside a future trial to estimate the 
sustainability of this approach. Data about usual care were not collected, but there is no 
expectation that this would have changed because of the intervention. 
Strengths of this trial include its randomised design reducing the risk of bias.28 Results were 
reported according to CONSORT guidelines for randomised pilot and feasibility trials.29 
Statistically significant results were attained as well as estimates of effect size that inform a 
future study. The trial protocol was adhered to, with the intervention resulting in 15 
additional therapy sessions for the experimental group, totalling an average of 226 minutes 
over the four-week study period. In an environment where treatment sessions are often 
limited to two sessions per week7 this represents a substantial increase in therapy.  
This trial counters concerns that family-assisted therapy will result in adverse events such as 
falls and caregiver burden. Previous research indicates physiotherapists can be hesitant to 
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involve families in therapy for this reason.12 There were no adverse events related to the 
intervention, with results suggesting a possible reduction in falls and caregiver strain, 
supporting the notion this approach is likely safe and not burdensome for family members. 
This outcome is consistent with results from other trials investigating family-assisted therapy 
after stroke.9, 10 Perhaps this is attributable to the training and support provided. Patients in 
the experimental group also took a mean of 944 more daily steps (95% CI 139-1748) which is 
comparable to findings from a systematic review of 13 physical activity intervention studies 
with a focus on older adults, showing a weighted increase of 775 steps per day.30 Although 
the number of daily steps increased may appear small the relative increase was large with 
participants in the experimental group doubling their mean daily step count. Sustained 
immobility can increase falls31 and promoting mobility in the hospital setting has been shown 
to prevent injurious falls.32 Risk associated with immobility may be more significant than risk 
associated with family-assisted therapy.  
There was no between-group difference observed for falls-related self-efficacy, a primary 
outcome for this trial. The intervention is likely ineffective for this outcome since the 
minimal clinically important difference is 3 units and this is the lower estimate of our 
confidence interval range. The primarily physical nature of the intervention may account for 
the lack of change in falls-related self-efficacy. Instead, a behavioural intervention may be 
expected to address this outcome more directly. Motivational interviewing has been shown to 
improve falls-related self-efficacy in people approximately six months after hip fracture33 of 
similar age to participants in this trial. Alternatively, the Berg Balance Scale34 may be an 
appropriate measure, having detected positive changes in other family-assisted therapy 
trials35, 36 and being validated for use with older adults.34 
A future definitive trial would require a sample size of n=138 (69 patients allocated to 
experimental and 69 allocated to the control group) to detect clinically important change 
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(standardised mean difference ≥ 0.5) in activity limitation, daily steps, caregiver strain, falls, 
balance and health-related quality of life, at a power of 0.8 and an alpha level of 0.05. A 
future trial would require resources so that people from culturally and linguistically diverse 
backgrounds could be included, to improve the generalisability of findings. Follow up at 
three and six months post-intervention would help determine the sustainability of post-
intervention effects. Hospital readmissions could also be measured, which could contribute to 
a health economic analysis, along with quality of life, length of stay and functional 
independence measures.  
The results of this pilot randomised controlled trial conducted in a Transition Care setting 
indicate that training and supporting families to assist with physiotherapy is likely safe, 
effective in improving daily steps and reducing activity limitation, and may lead to a 
reduction in falls without increasing caregiver strain. A phase III randomised controlled trial 
could help confirm these preliminary findings.  
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Clinical messages 
• Family-assisted therapy is likely to be a safe intervention for older people 
transitioning from hospital to the community and their families 
• Physiotherapy augmented by family-assisted therapy increased daily steps taken, 
reduced activity limitation, and may have reduced falls without increasing caregiver 
strain  
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 Table 1. Baseline characteristics of patients and family members 
 
Characteristic Randomised 
(n = 35) 
 Exp 
(n = 17) 
Con 
(n = 18) 
PATIENTS   
Age (yr), mean (SD) 83 (6) 85 (6) 
Gender, n males  7 7 
Country of birth, n    
Australia 9 13 
United Kingdom 5 2 
Other 3 3 
Diagnosis, n   
Fracture after fall 7 7 
Fall with no fracture 0 3 
Deconditioning 4 2 
Stroke 3 2 
Delirium 1 2 
Other 2 2 
Charlson comorbidity index, mean (SD) 4 (2) 3 (2) 
Gait aid, n   
Nil 1 1 
Walking frame 15 15 
Standing or transferring only 1 2 
Assistance required to stand or walk, n    
Independent 4 5 
Supervision 10 9 
Assistance of one person 3 4 
Presence of cognitive impairment, n  6 10 
FAMILY MEMBERS (n=20) † (n=20) † 
Age (yr), mean (SD) 54 (15) 61 (11) 
Gender, n males 6 5 
Relationship to patient, n    
Spouse 3 1 
Son 3 5 
Daughter 9 11 
Sibling 1 1 
Other 4 2 
Highest level of education, n   
Secondary school or below 7 9 
Tertiary 13 11 
Work status, n   
Full time 3 6 
Part time 8 3 
Self employed 3 3 
Retired 4 8 
Other 2 0 
Exp = experimental group, Con = control group 
†Note: Five patient participants nominated two family members for the trial
 Table 2. Intervention. 
 
Activities Mean (SD) 
PHYSIOTHERAPIST TRAINING AND SUPPORT (per patient) 
Visits to Transition Care site, n 2 (2) 
Visits to home or other location, n 1 (1) 
Visits conducted outside business hours, n 1 (1) 
Face-to-face time spent (minutes) 120 (50) 
Telephone calls, n 1 (1) 
Telephone calls, time (minutes) 3 (5) 
Emails or text messages, n 3 (3) 
Emails or text messages, time (minutes) 8 (9) 
Total time over 4 weeks (minutes) 130 (49) 
FAMILY-ASSISTED THERAPY (per patient)  
Therapy sessions over 4 weeks, n 15 (8) 
Time per session (minutes) 15 (16) 
Total therapy over 4 weeks (minutes) 226 (210) 
 Table 3. Mean (SD) of groups, mean (SD) difference within groups, and mean (95% CI) difference between groups. 
 
Outcome Groups  Difference within groups  Difference between groups 
 Week 0  Week 5  Week 5 minus Week 0§  Week 5 minus Week 0†  SMD (95% CI) 
 Exp 
(n = 17) 
Con 
(n = 18) 
 Exp 
(n = 15) 
Con 
(n = 16) 
 Exp Con  Exp minus Con  Week 5 
Short Falls Efficacy Scale – 
international‡ (7 to 28) 
14.4e 
(4.9) 
14.2f 
(5.2) 
 14.4c 
(3.5) 
14.8c 
(4.6) 
 -0.8 
(3.5) 
0.1 
(4.1) 
 -0.7 
(-3.0 to 1.7) 
 0.2 (-0.5 to 1.0) 
Physical activity             
     Time in sitting/lying (hrs) 22.2c 
(1.3) 
22.4f 
(1.4) 
 20.6a 
(1.5) 
21.4d 
(2.0) 
 -1.5 
(1.8) 
-1.0 
(1.0) 
 -0.6 
(-1.7 to 0.6) 
 0.4 (-0.4 to 1.1) 
     Time standing (hrs) 1.5c 
(1.2) 
1.4f 
(1.2) 
 2.9a 
(1.4) 
2.3d 
(1.9) 
 1.2 
(1.7) 
0.9 
(0.9) 
 0.3 
(-0.8 to 1.4) 
 0.2 (-0.6 to 1.0) 
     Time stepping (hrs) 0.3c 
(0.3) 
0.3f 
(0.4) 
 0.5a 
(0.3) 
0.3d 
(0.4) 
 0.3 
(0.3) 
0.0 
(0.4) 
 0.2 
(-0.001 to 0.5) 
 0.8 (0.0 to 1.6) 
     Steps per day (n) 995c 
(895.0) 
942f 
(1211.5) 
 1986a 
(1216.3) 
1073d 
(1190.5) 
 1028 
(1093.6) 
67 
(1003.2) 
 944* 
(139.0 to 1748.4) 
 0.9* (0.1 to 1.7) 
EQ-5D-3L index (0 to 1) 0.6d 
(0.3) 
0.6 
(0.2) 
 0.6b 
(0.2) 
0.6e 
(0.2) 
 0.0 
(0.3) 
0.0 
(0.3) 
 0.0 
(-0.2 to 0.1) 
 0.0 (-0.7 to 0.7) 
EQ-5D-3L Visual analogue scale 
(0 to 100) 
66.9 
(17.2) 
67.2 
(16.3) 
 70.7d 
(13.9) 
70.4d 
(14.9) 
 4.1 
(16.4) 
1.9 
(13.7) 
 1.2 
(-8.1 to 10.5) 
 0.1 (-0.6 to 0.9) 
ICECAP-O tariff (0 to 1) 0.8c 
(0.1) 
0.8f 
(0.1) 
 0.8b 
(0.1) 
0.8d 
(0.1) 
 0.0 
(0.1) 
0.0 
(0.1) 
 0.0 
(-0.1 to 0.1) 
 0.0 (-0.7 to 0.7) 
Modified Caregiver Strain Index 
(0 to 26) 
8.9 
(4.8) 
6.7 
(4.5) 
 7.7d 
(4.2) 
6.9d 
(4.7) 
 -1.0 
(3.1) 
0.8 
(3.2) 
 -1.2 
(-3.6 to 1.2) 
 0.6 (-0.2 to 1.3) 
Exp = experimental group; Con = control group; SMD = standardised mean difference; ‡Lower score indicates lower concern, estimated minimal clinically important difference 
= 3 units; §= derived from paired t-tests; †= derived from ANCOVA with dependent variable at baseline as covariate; * p<.05; a n=11; b n=13; c n=14; d n=15; e n=16; f n=17 
  
 
 
Figure 1. Design and flow of participants through the trial. 
 
 
Control Group 
• Usual 
physiotherapy 
care 
Patients flagged by Transition Care 
staff assessed for eligibility (n=81) 
Excluded (n = 46) 
• Not meeting inclusion criteria (n=9) 
• Patient declined to participate (n=13) 
• Family declined to participate (n=24) 
Measured falls related self-efficacy, quality of life and caregiver strain, physical activity 
measured via activity monitor for 3-7 days 
 
Randomised (n = 35) 
(n = 17)      (n = 18) 
Week 0 
Experimental Group 
• Usual physiotherapy 
care 
• Therapy activities 
with family > 3 x per 
week 
• Training/support from 
physiotherapist > 1 x 
  
Week 5 Measured number of falls Week 0 – Week 5, falls related self-efficacy, quality of life 
and caregiver strain, physical activity measured via activity monitor for 3-9 days. 
 
 (n = 16)      (n = 18) 
Lost to Week 5 
follow-up 
• deceased (n = 1) 
 
